期刊
EXPERT REVIEW OF PROTEOMICS
卷 13, 期 4, 页码 435-445出版社
TAYLOR & FRANCIS LTD
DOI: 10.1586/14789450.2016.1159960
关键词
Epigenetics; histone acetylation; high-throughput sequencing; chromatin modifications; HDAC inhibitors
Many epigenetic-based therapeutics, including drugs such as histone deacetylase inhibitors, are now used in the clinic or are undergoing advanced clinical trials. The study of chromatin-modifying proteins has benefited from the rapid advances in high-throughput sequencing methods, the organized efforts of major consortiums and by individual groups to profile human epigenomes in diverse tissues and cell types. However, while such initiatives have carefully characterized healthy human tissue, disease epigenomes and drug-epigenome interactions remain very poorly understood. Reviewed here is how high-throughput sequencing improves our understanding of chromatin regulator proteins and the potential implications for the study of human disease and drug development and discovery.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据